NCT02153424View on ClinicalTrials.gov

Early Post-marketing Study of Eliquis (Apixaban)

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

April 30, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Non-valvular Atrial Fibrillation (NVAF)
Interventions
DRUG

Apixaban

Trial Locations (2)

72040

Local Institution, Puebla City

442003

Local Institution, Guadalajara

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY